Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Jun;19(2):186-203.
doi: 10.1007/s11065-009-9095-0. Epub 2009 May 27.

Functional consequences of HIV-associated neuropsychological impairment

Ashley A Gorman  1 , Jessica M Foley, Mark L Ettenhofer, Charles H Hinkin, Wilfred G van Gorp
Affiliations
Review

Functional consequences of HIV-associated neuropsychological impairment

Ashley A Gorman et al. Neuropsychol Rev. 2009 Jun.

Abstract

This review focuses on the "real world" implications of infection with HIV/AIDS from a neuropsychological perspective. Relevant literature is reviewed which examines the relationships between HIV-associated neuropsychological impairment and employment, driving, medication adherence, mood, fatigue, and interpersonal functioning. Specifically, the relative contributions of medical, cognitive, psychosocial, and psychiatric issues on whether someone with HIV/AIDS will be able to return to work, adhere to a complicated medication regimen, or safely drive a vehicle will be discussed. Methodological issues that arise in the context of measuring medication adherence or driving capacity are also explored. Finally, the impact of HIV/AIDS on mood state, fatigue, and interpersonal relationships are addressed, with particular emphasis on how these variables interact with cognition and independent functioning. The purpose of this review is to integrate neuropsychological findings with their real world correlates of functional behavior in the HIV/AIDS population.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
CVLT Baseline Predicts Finding Employment. Note: Adapted from van Gorp, W., Rabkin, J.G., Ferrando, S.J., Mintz, J., Ryan, E., Borkowski,T., & Mcelhiney, M. (2007). Neuropsychiatric predictors of return to work in HIV/AIDS. Journal of the International Neuropsychological Society, 13, 80-89 (reprinted with permission)
Fig. 2
Fig. 2
Cognition and Medication Adherence among Younger and Older HIV+ Adults. Note: Mem. = Memory; Attent. = Attention; Exec. = Executive; Qual. = Qualitative self-report; 30-Day = 30-Day Self-Report; 1-Day = 1-Day Self-Report. Standardized values shown. Adapted from Ettenhofer, M. L., Hinkin, C. H., Castellon, S. A., Durvasula, R., Ullman, J., Lam, M., Myers, H., Wright, M. J., & Foley, J. (in press). Aging, neurocognition, and medication adherence in HIV infection. American Journal of Geriatric Psychiatry
Fig. 3
Fig. 3
Accidents per Million Miles in Past Year for HIV+ Groups Stratified by Neuropsychological Impairment and Risk Level*. Note: Adapted from Marcotte, T.D., Lazzaretto, D., Scott, J.C., Roberts, E., Woods, S.P., Letendre, S., & the HNRC Group. (2006). Visual attention deficits are associated with driving accidents in cognitively-impaired HIV-infected individuals. Journal of Clinical and Experimental Neuropsychology, 28, 13–28. *Risk Level: Classified based upon Useful Field of View (UFOV) task performance. NP: Neuropsychologically
See this image and copyright information in PMC

References

    1. Albert SM, Marder K, Dooneief G, Bell K, Sano M, Todak G, et al. Neuropsychological impairment in early HIV infection: a risk factor for work disability. Archives of Neurology. 1995;52:525–530. - PubMed
    1. Albert SM, Weber CM, Todak G, Polanco C, Clouse R, McElhiney M, et al. An observed performance test of medication management ability in HIV: relation to neuropsychological status and medication adherence outcomes. AIDS and Behavior. 1999;3(2):121–128.
    1. Ances BM, Ellis RJ. Dementia and neurocognitive disorders due to HIV-1 infection. Seminars in Neurology. 2007;27(1):86–92. - PubMed
    1. Arnsten JH, Demas RA, Farzadegan H, Grant RW, Gourevitch MN, Chang CJ, et al. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clinical Infectious Diseases. 2001;33(8):1417–1423. - PMC - PubMed
    1. Atkinson JH, Grant I, Kennedy CJ, Richman DD, Spector SA, McCutchan JA. Prevalence of psychiatric disorders among men infected with human immunodeficiency virus: a controlled study. Archives of General Psychiatry. 1988;45(9):859–864. - PubMed

MeSH terms

Substances